CXCL-10 levels increased significantly in CRC patients compared to control subjects (65), and a recent meta-analysis revealed significant associations between low CXCL-10 expression and good overall, disease-free and relapse-free survival of CRC patients (66). Here, CXCL10 is linked to colorectal carcinoma.